,

Radionuclide Therapy Fellow - 2021

Job posted: 09/10/2020
Applications close: 08/11/2020 (Midnight)
11 days remaining

11 days remaining

Job Description

Location: Melbourne

Job type: Not provided

Organisation: Peter MacCallum Cancer Centre

Salary: Salary not specified

Occupation: Medical

Reference: 19298

Reference: 19298

Occupation: Medical

Salary Range: Salary not specified

Work location: Melbourne


Radionuclide Therapy Fellow


 


Department of  Cancer Imaging


Full time – 6-12 months Contract commencing 1 February 2021



Eligible candidates are encouraged to apply for this position now open at Peter MacCallum Cancer Centre – a place where our normal days are extraordinary; as are the people we care for. This would be an ideal opportunity for nuclear medicine trainees who have completed their core training and seek further experience in radionuclide therapy. Radiation oncology and medical oncology trainees who have completed their core training and are interested in Lu-PSMA and Lu-Tate therapy as well as accredited endocrinology trainees with interest in thyroid cancer and Lu-Tate therapy in rare endocrine syndromes and functional neuroendocrine tumours would also be suitable candidates for this role.



Peter Mac is one of a handful of integrated cancer research, education and treatment centres in the world. Each day our team strives to provide the very best in cancer care, even better treatments and potential cancer cures for all people affected by cancer.



Globally, we are facing one of the most pivotal times in the pursuit of cancer cures, and Peter Mac stands at its forefront. Together, we aim to lead a new era of cancer prevention, care and discovery, supported by state-of-the-art facilities at our new home within the Victorian Comprehensive Cancer Centre building.



Your role in our future.



We have an integrated large radionuclide therapy facility for both outpatient and inpatient care including paediatrics and perform over 300 radionuclide therapies per year with Lu-177, Y-90 or I-131 for malignancies including neuroendocrine, prostate, thyroid and lymphoma. Our Cancer Imaging centre provides a high-level service in cancer diagnosis, staging, therapeutic monitoring and research. We perform more than 9000 PET/CT scans per annum including many non-FDG studies with various radiotracers such as F-18, Ga-68, Cu-64, I-124 and Zr-89 for both clinical and research purposes including first in-human studies.



You would be working in therapeutic nuclear medicine, which is mostly an outpatient service, and primarily involved in patient’s initial visit, ongoing therapy and follow up with opportunities to be involved in research. Participation in pre-existing or new research projects for presentation or publication is strongly encouraged.



The position is not accredited by the AANMS for a core year of advanced training in nuclear medicine.



A medical degree and registration with the Medical Board of Australia are pre-requisites for appointment. You will need to either have completed one year of accredited core training in nuclear medicine or completed your core training years in medical oncology, radiation oncology or endocrinology.



Peter Mac offers its employees the following benefits:


• Salary Packaging


• Central City Location


• Employee Assistance Program


• Training and Development Program


Radionuclide Therapy Fellow - 2021

Job type:

Not provided

Job classification:

Not provided

Contact:

Dr Ramin Alipour - 8559 7843
ramin.alipour@petermac.org
Professor Rod Hicks - 85596618
rod.hicks@petermac.org

Radionuclide Therapy Fellow - 2021